Addiction Medicine
From the Journals
Transcranial magnetic stimulation shows promise for alcohol addiction
Dr. Markus Heilig now hopes to carry out a multisite phase 3 study of the intervention.
Conference Coverage
Many clinicians feel ill-prepared for drug overdose deaths
A patient overdose death can change clinical decision-making for providers experiencing high levels of stress related to the death.
Conference Coverage
Most addiction specialists support legalized therapeutic psychedelics
Most respondents wanted legal therapeutic psychedelics to be administered only in controlled settings.
Conference Coverage
Is prescribing stimulants OK for comorbid opioid use disorder, ADHD?
One new study showed that from 2007-2017, there was a threefold increase in OUD and comorbid ADHD.
Conference Coverage
Women struggle with benzodiazepine addiction post chemotherapy treatment
Sedatives like benzodiazepines are used to control nausea, anxiety, and insomnia during chemotherapy treatment, but overuse and failing to taper...
Feature
Boom in sports betting spurs new guidance on gambling disorder
There are no FDA-approved drugs for gambling disorder, but new evidence supports the use of certain agents, such as naltrexone and OTC N-...
From the Journals
Short-acting opioids needed for withdrawal in U.S. hospitals, say experts
The short-acting drugs can complement methadone and buprenorphine to help patients get faster relief and help patients stay in the hospital to...
From the Journals
Lithium’s antisuicidal effects questioned
The researchers note that the study did not reach its original recruitment goal.
News
U.S. overdose deaths hit an all-time high
Fentanyl and methamphetamine are contributing to rising numbers of fatalities, federal officials say.
Conference Coverage
Alcohol-related liver disease severity increased during COVID-19 pandemic
Increased alcohol sales and disrupted services may have led to worse clinical outcomes.
Conference Coverage
Warn patients about illicit drugs doctored with fentanyl
Most patients with drug use disorders are testing positive for fentanyl at his center, said Dr. Edwin A. Salsitz, of Mount Sinai Beth Israel.